Al18F-HER2-BCH PET

· Peking University Cancer Hospital & Institute

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Al18F-HER2-BCH PET, covering 2025-04-03 to 2025-04-03. Get the full timeline:

Most recent: Clinical Trial Update: Al18F-HER2-BCH PET in Breast Patients Treated With Neoadjuvant Therapy [NA]